Riskpilot← Back to searchSign inGet full accessOLANDER CLINICAL CONSULTING 1 ApS
APSActiveCVR 35532900Skibsegen 70Research and experimental development on natural sciences and engineering · NACE 7210Est. 20130 employees
Revenue 2024
DKK 0
EBITDA margin
—
+87% vs 2023
Equity ratio
92.2%
Financial strength
Net profit 2024
DKK 31K
+30% vs 2023
| Revenue | DKK 0 | — |
| EBITDA | DKK -1K | +87% |
| Net profit | DKK 31K | +30% |
| Total assets | DKK 150K | +27% |
| Equity | DKK 139K | +29% |
| Employees | 0 | — |
Legal name
OLANDER CLINICAL CONSULTING 1 ApS
CVR number
35532900
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
19. november 2013
Share capital
DKK 80.000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at drive virksomhed med klinisk forskning, samt enhver i forbindelse hermed stående virksomhed.
Address
Skibsegen 70
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 464 | -16 | -9 | -12 | -8 | -6 | -6 | -7 | -7 | 0 | 0 |
| Staff expenses | -289 | -166 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 175 | -182 | -9 | -12 | -8 | -6 | -6 | -7 | -7 | -8 | -1 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 175 | -182 | -9 | -12 | -8 | -6 | -6 | -7 | -7 | -8 | -1 |
| Net financials | 11 | 16 | 30 | 26 | 34 | 29 | 30 | 35 | 38 | 38 | 41 |
| Profit before tax | 186 | -165 | 21 | 14 | 27 | 22 | 23 | 29 | 31 | 30 | 40 |
| Tax | 46 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 1 | 7 | 9 |
| Net profit | 140 | -165 | 21 | 14 | 27 | 22 | 23 | 29 | 30 | 24 | 31 |
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 302 | 89 | 79 | 93 | 126 | 142 | 108 | 113 | 119 | 118 | 150 |
| Equity | 220 | 55 | 75 | 90 | 116 | 108 | 104 | 109 | 114 | 108 | 139 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 82 | 34 | 4 | 4 | 10 | 34 | 4 | 4 | 5 | 10 | 12 |
| Total debt | 82 | 34 | 4 | 4 | 10 | 34 | 4 | 4 | 5 | 10 | 12 |
EBITDA margin
-100400.0%
This company
15.8%
Market median
-635543% vs market
20142024
Equity ratio
92.2%
This company
38.2%
Market median
+141% vs market
20142024
Return on equity
22.3%
This company
18.4%
Market median
+21% vs market
20142024
Net profit margin
3097900.0%
This company
8.1%
Market median
+38245579% vs market
20142024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20142024
Debt / equity
0.08×
This company
0.62×
Market median
+87% vs market
20142024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2013-11-19 – 2014-12-31
No data on file.
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2013 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of OLANDER CLINICAL CONSULTING 1 ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|